Rhino-orbital Mucormycosis presenting as facial cellulitis in a patient with high-risk acute myeloid leukemia in relapse.
暂无分享,去创建一个
M. Mohty | F. Giannotti | E. Brissot | J. Guitard | A. Ruggeri | O. Paccoud | F. Malard | R. Duléry | B. Baujat | G. Battipaglia | P. Debureaux
[1] D. Kontoyiannis,et al. Breakthrough Invasive Mold Infections in the Hematology Patient: Current Concepts and Future Directions , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] L. Pagano,et al. ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients , 2016, Haematologica.
[3] W. G. Nichols,et al. Efficacy of transfusion with granulocytes from G-CSF/dexamethasone-treated donors in neutropenic patients with infection. , 2015, Blood.
[4] C. Elie,et al. Local control of rhino-orbito-cerebral mucormycosis dramatically impacts survival. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[5] H. Kantarjian,et al. Treatment of neutropenia-related fungal infections with granulocyte colony-stimulating factor-elicited white blood cell transfusions: a pilot study , 1997, Leukemia.